Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Polymer Materials (APM) is a specialized biotechnology company focused on the development and manufacture of high-purity functional polymers for drug delivery and medical device applications. Based in Montreal, the company provides a wide range of biodegradable and biocompatible polymers, including PEG derivatives, PLGA, and various block copolymers used to enhance the solubility and stability of therapeutic agents. APM's technology is critical for the formulation of advanced drug delivery systems such as nanoparticles, micelles, and hydrogels. The company serves as a key partner for pharmaceutical and biotech firms by providing custom synthesis and high-quality materials for both research and clinical-stage programs. Their expertise lies in precise polymer architecture, which allows for controlled release and targeted delivery of small molecules and biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APM.